MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Longitudinal study of clinical symptoms associated with psychosis in Parkinson’s disease without dementia

J. Flanigan, M. Harrison, B. Shah, J. Patrie, K. Wyman-Chick, W. Dalrymple, S. Sperling, M. Barrett (Charlottesville, USA)

Meeting: 2022 International Congress

Abstract Number: 811

Keywords: Cognitive dysfunction, Depression, Psychosis

Category: Parkinson's Disease: Psychiatric Manifestations

Objective: Examine clinical features associated with psychosis among Parkinson’s disease (PD) patients without dementia.

Background: Previously identified risk factors for PD psychosis include duration and severity of PD, autonomic dysfunction, REM sleep behavior disorder, daytime somnolence, and cognitive impairment. Little is known regarding PD psychosis in patients without dementia. Prior research has not clearly established the frequency with which minor hallucinations progress to more complex psychotic symptoms, such as well-formed visual hallucinations, hallucinations in other modalities, and delusions.

Method: Participants met the following inclusion criteria: 1) ≥ 30-years old at onset of first motor symptom, 2) ≤ 85 years of age, 3) diagnosis of idiopathic PD based on the UK Brain Bank criteria, and 4) Montreal Cognitive Assessment (MoCA) >21. The presence of psychosis was defined as the recurring presence of at least one of the following symptoms for at least one month: visual illusions, sense of presence, hallucinations, or delusions. Motor, autonomic, sleep, mood, and cognitive symptoms were evaluated.

Results: A total of 105 participants completed baseline visits (59% men; age = 67.8 ± 8.0 years; disease duration =4.9 years [IQR: 3.4-7.7]; UPDRS-III =24 [IQR 16-36]; MoCA = 24.8 ± 2.3), 92 completed year-one visits, 74 completed year-two visits, and 67 completed year-three visits. The prevalence of psychosis increased during the study from 31% (n=32) at baseline to 39% (n=26) at year three. Over three years, 43% (n=45) experienced psychosis. Of the 120 psychotic events, visual illusions were the most common (70%, n=84), followed by hallucinations (58.3%, n=70). Isolated minor hallucinations accounted for 39.2% (n=47) of psychotic events. In multivariate analysis of clinical features, only depressive symptoms (Beck Depression Inventory-II) significantly increased the odds of psychosis (OR 1.09, 95% CI: [1.03, 1.16], p=.004).  Of the cognitive assessments, only worse performance on Trail-Making Test B-A significantly increased the odds of psychosis (OR 1.43, 95% CI: [1.06, 1.93], p=.018).

Conclusion: In non-demented patients with PD, depressive symptoms and executive dysfunction were associated with increased risk of psychosis. Executive dysfunction may mark the transition from isolated minor hallucinations to more complex psychotic symptoms.

To cite this abstract in AMA style:

J. Flanigan, M. Harrison, B. Shah, J. Patrie, K. Wyman-Chick, W. Dalrymple, S. Sperling, M. Barrett. Longitudinal study of clinical symptoms associated with psychosis in Parkinson’s disease without dementia [abstract]. Mov Disord. 2022; 37 (suppl 2). https://www.mdsabstracts.org/abstract/longitudinal-study-of-clinical-symptoms-associated-with-psychosis-in-parkinsons-disease-without-dementia/. Accessed May 14, 2025.
  • Tweet
  • Email
  • Print

« Back to 2022 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/longitudinal-study-of-clinical-symptoms-associated-with-psychosis-in-parkinsons-disease-without-dementia/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley